000 | 01930 a2200529 4500 | ||
---|---|---|---|
005 | 20250513184825.0 | ||
264 | 0 | _c19990722 | |
008 | 199907s 0 0 eng d | ||
022 | _a0022-5223 | ||
024 | 7 |
_a10.1016/S0022-5223(99)70152-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKayano, K | |
245 | 0 | 0 |
_aSuperior protection in orthotopic rat lung transplantation with cyclic adenosine monophosphate and nitroglycerin-containing preservation solution. _h[electronic resource] |
260 |
_bThe Journal of thoracic and cardiovascular surgery _cJul 1999 |
||
300 |
_a135-44 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenosine _xchemistry |
650 | 0 | 4 |
_aAllopurinol _xchemistry |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
650 | 0 | 4 |
_aCyclic AMP _xpharmacology |
650 | 0 | 4 |
_aDextrans _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 |
_aGlutathione _xchemistry |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 |
_aHypertonic Solutions _xchemistry |
650 | 0 | 4 |
_aInsulin _xchemistry |
650 | 0 | 4 | _aLung Transplantation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
650 | 0 | 4 |
_aOrgan Preservation Solutions _xchemistry |
650 | 0 | 4 |
_aPulmonary Circulation _xdrug effects |
650 | 0 | 4 |
_aRaffinose _xchemistry |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
700 | 1 | _aToda, K | |
700 | 1 | _aNaka, Y | |
700 | 1 | _aOkada, K | |
700 | 1 | _aOz, M C | |
700 | 1 | _aPinsky, D J | |
773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 118 _gno. 1 _gp. 135-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0022-5223(99)70152-2 _zAvailable from publisher's website |
999 |
_c10342549 _d10342549 |